A detailed history of Legal & General Group PLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 23,554,443 shares of MRK stock, worth $2.36 Billion. This represents 0.57% of its overall portfolio holdings.

Number of Shares
23,554,443
Previous 23,554,443 -0.0%
Holding current value
$2.36 Billion
Previous $2.67 Billion -0.0%
% of portfolio
0.57%
Previous 0.57%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $14.3 Million - $16.5 Million
128,276 Added 0.55%
23,554,443 $2.67 Billion
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $6.19 Million - $6.65 Million
50,035 Added 0.21%
23,426,167 $2.9 Billion
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $13.1 Million - $15.2 Million
-115,534 Reduced 0.49%
23,376,132 $3.08 Billion
Q4 2023

Feb 15, 2024

BUY
$100.18 - $109.02 $336 Million - $365 Million
3,351,979 Added 16.64%
23,491,666 $2.56 Billion
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $56.2 Million - $62.4 Million
-545,917 Reduced 2.64%
20,139,687 $2.07 Billion
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $119 Million - $130 Million
1,097,735 Added 5.6%
20,685,604 $2.39 Billion
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $41 Million - $45.7 Million
398,252 Added 2.08%
19,587,869 $2.08 Billion
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $45 Million - $57.7 Million
-514,995 Reduced 2.61%
19,189,617 $2.13 Billion
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $48.6 Million - $54.6 Million
-575,045 Reduced 2.84%
19,704,612 $1.7 Billion
Q2 2022

Aug 22, 2022

SELL
$83.49 - $94.64 $1.45 Million - $1.65 Million
-17,399 Reduced 0.09%
20,279,657 $1.85 Billion
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $87.7 Million - $98.3 Million
1,192,643 Added 6.24%
20,297,056 $1.67 Billion
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $882,755 - $1.11 Million
-12,213 Reduced 0.06%
19,104,413 $1.46 Billion
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $59.7 Million - $65.6 Million
832,409 Added 4.55%
19,116,626 $1.44 Billion
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $89.3 Million - $98.7 Million
1,269,432 Added 7.46%
18,284,217 $1.42 Billion
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $17.9 Million - $21.1 Million
-260,298 Reduced 1.51%
17,014,785 $1.31 Billion
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $17.9 Million - $19.9 Million
249,739 Added 1.47%
17,275,083 $1.41 Billion
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $16.2 Million - $18.4 Million
-221,817 Reduced 1.29%
17,025,344 $1.41 Billion
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $22.3 Million - $25.4 Million
316,699 Added 1.87%
17,247,161 $1.33 Billion
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $32 Million - $44.3 Million
504,582 Added 3.07%
16,930,462 $1.3 Billion
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $51.1 Million - $57.7 Million
658,998 Added 4.18%
16,425,880 $1.49 Billion
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $2.04 Million - $2.22 Million
26,805 Added 0.17%
15,766,882 $1.33 Billion
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $12.1 Million - $14.2 Million
-173,642 Reduced 1.09%
15,740,077 $1.32 Billion
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $173 Million - $197 Million
2,482,234 Added 18.48%
15,913,719 $1.32 Billion
Q4 2018

Feb 15, 2019

BUY
$65.24 - $75.71 $42.6 Million - $49.4 Million
653,128 Added 5.11%
13,431,485 $1.03 Billion
Q3 2018

Nov 20, 2018

SELL
$57.69 - $67.84 $229,952 - $270,410
-3,986 Reduced 0.03%
12,778,357 $906 Million
Q2 2018

Aug 10, 2018

SELL
$50.83 - $59.72 $35.5 Million - $41.7 Million
-698,229 Reduced 5.18%
12,782,343 $776 Million
Q1 2018

May 17, 2018

SELL
$50.96 - $59.23 $43.4 Million - $50.4 Million
-850,774 Reduced 5.94%
13,480,572 $734 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $740 Million - $883 Million
14,331,346
14,331,346 $806 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.